Adam Palanica

Dr. Adam Palanica

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
APAdam Palanica
Adam Palanica
PFPeter Flaschner
Peter Flaschner
ATAnirudh Thommandram
Anirudh Thommandram
MLMichael Li
Michael Li
YFYan Fossat
Yan Fossat
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Many potential benefits have been theorized on the uses for chatbots within the context of healthcare, such as improved patient education and treatment compliance. However, little is known about the perspectives of practicing medical physicians on the use of chatbots in healthcare, even though these individuals are the traditional benchmark of proper patient care. Objective: This study investigates the perceptions of physicians regarding the use of healthcare chatbots, including their benefits, challenges, and risks to patients. Methods: One hundred (100) practicing physicians across the United States completed a web-based, self-report survey to examine their opinions of chatbot technology in healthcare. Descriptive statistics and frequencies were used to examine the characteristics of participants. Results: A wide variety of positive and negative perspectives were reported on the use of healthcare chatbots, including the importance to patients for managing their own health, and the benefits on physical, psychological, and behavioral health outcomes. More consistent agreement occurred with regard to administrative benefits associated with chatbots; many physicians believed that chatbots would be most beneficial for scheduling doctor appointments (78%), locating health clinics (76%), or providing medication information (71%). Conversely, many physicians believed that chatbots cannot effectively care for all of patients’ needs (76%), cannot display human emotion (72%), and cannot provide detailed diagnosis and treatment due to not knowing all of the personal factors associated with the patient (71%). Many physicians also stated that healthcare chatbots could be a risk to patients if they self-diagnose too often (74%) and do not accurately understand the diagnoses (74%). Conclusions: Physicians believe in both costs and benefits associated with chatbots, depending on the logistics and specific roles of the technology. Chatbots may have a beneficial role to play in healthcare to support, motivate, and coach patients, as well as for streamlining organizational tasks; in essence, chatbots could become a surrogate for non-medical caregivers. However, concerns remain on the inability of chatbots to comprehend the emotional state of humans, as well as in areas where expert medical knowledge and intelligence is required.

1 June 2019 in Journal of Environmental Psychology
Verified
Journal Article
Closed access
APAdam Palanica
Adam Palanica
ALAleksandra Lyons
Aleksandra Lyons
MCMadeline Cooper
Madeline Cooper
ALAndrew Lee
Andrew Lee
YFYan Fossat
Yan Fossat

20 June 2019 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
APAdam Palanica
Adam Palanica
ATAnirudh Thommandram
Anirudh Thommandram
ALAndrew Lee
Andrew Lee
MLMichael Li
Michael Li
YFYan Fossat
Yan Fossat
This study investigated the speech recognition abilities of popular voice assistants when being verbally asked about commonly dispensed medications by a variety of participants. Voice recordings of 46 participants (12 of which had a foreign accent in English) were played back to Amazon’s Alexa, Google Assistant, and Apple’s Siri for the brand- and generic names of the top 50 most dispensed medications in the United States. A repeated measures ANOVA indicated that Google Assistant achieved the highest comprehension accuracy for both brand medication names (M = 91.8%, SD = 4.2) and generic medication names (M = 84.3%, SD = 11.2), followed by Siri (brand names M = 58.5%, SD = 11.2; generic names M = 51.2%, SD = 16.0), and the lowest accuracy by Alexa (brand names M = 54.6%, SD = 10.8; generic names M = 45.5%, SD = 15.4). An interaction between voice assistant and participant accent was also found, demonstrating lower comprehension performance overall for those with a foreign accent using Siri (M = 48.8%, SD = 11.8) and Alexa (M = 41.7%, SD = 12.7), compared to participants without a foreign accent (Siri M = 57.0%, SD = 11.7; Alexa M = 53.0%, SD = 10.9). No significant difference between participant accents were found for Google Assistant. These findings show a substantial performance lead for Google Assistant compared to its voice assistant competitors when comprehending medication names, but there is still room for improvement.

8 April 2020 in Digital Biomarkers
Verified
Journal Article
Open access
PDF file
APAdam Palanica
Adam Palanica
MDMichael J. Docktor
Michael J. Docktor
MLMichael Lieberman
Michael Lieberman
YFYan Fossat
Yan Fossat
Digital therapeutics is a newly described concept in healthcare which is proposed to change patient behavior and treat medical conditions using a variety of digital technologies. However, the term is rarely defined with criteria that make it distinct from simply digitizedversions of traditional therapeutics. Our objective is to describe a more valuable characteristic of digital therapeutics, which is distinct from traditional medicine or therapy: that is, the utilization of artificial intelligence and machine learning systems to monitor and predict individual patient symptom data in an adaptive clinical feedback loop via digital biomarkers to provide a precision medicine approach to healthcare. Artificial intelligence platforms can learn and predict effective interventions for individuals using a multitude of personal variables to provide a customized and more tailored therapy regimen. Digital therapeutics coupled with artificial intelligence and machine learning also allows more effective clinical observations and management at the population level for various health conditions and cohorts. This vital differentiation of digital therapeutics compared to other forms of therapeutics enables a more personalized form of healthcare that actively adapts to patients’ individual clinical needs, goals, and lifestyles. Importantly, these characteristics are what needs to be emphasized to patients, physicians, and policy makers to advance the entire field of digital healthcare.

25 March 2019 in Perspectives on Medical Education
Verified
Journal Article
Open access
PDF file
APAdam Palanica
Adam Palanica
MDMichael J. Docktor
Michael J. Docktor
ALAndrew Lee
Andrew Lee
YFYan Fossat
Yan Fossat
Patients are typically debriefed by their healthcare provider after any medical procedure or surgery to discuss their findings and any next steps involving medication or treatment instructions. However, without any medical or scientific background knowledge, it can feel overwhelming and esoteric for a patient to listen to a physician describe a complex operation. Instead, providing patients with engaging visuals and a virtual reality (VR) simulation of their individual clinical findings could lead to more effective transfer of medical knowledge and comprehension of treatment information. A newly developed VR technology is described, called HealthVoyager, which is designed to help facilitate this knowledge transfer between physicians and patients. The platform represents a customizable, VR software system utilizing a smartphone or tablet computer to portray personalized surgical or procedural findings as well as representations of normal anatomy. The use of such technology for eliciting medical understanding and patient satisfaction can have many practical and clinical applications for a variety of disease states and patient populations.

2 October 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JJJouHyun Jeon
JouHyun Jeon
GBGaurav Baruah
Gaurav Baruah
SSSarah Sarabadani
Sarah Sarabadani
APAdam Palanica
Adam Palanica
Background: In December 2019, the COVID-19 outbreak started in China and rapidly spread around the world. Lack of a vaccine or optimized intervention raised the importance of characterizing risk factors and symptoms for the early identification and successful treatment of patients with COVID-19. Objective: This study aims to investigate and analyze biomedical literature and public social media data to understand the association of risk factors and symptoms with the various outcomes observed in patients with COVID-19. Methods: Through semantic analysis, we collected 45 retrospective cohort studies, which evaluated 303 clinical and demographic variables across 13 different outcomes of patients with COVID-19, and 84,140 Twitter posts from 1036 COVID-19–positive users. Machine learning tools to extract biomedical information were introduced to identify mentions of uncommon or novel symptoms in tweets. We then examined and compared two data sets to expand our landscape of risk factors and symptoms related to COVID-19. Results: From the biomedical literature, approximately 90% of clinical and demographic variables showed inconsistent associations with COVID-19 outcomes. Consensus analysis identified 72 risk factors that were specifically associated with individual outcomes. From the social media data, 51 symptoms were characterized and analyzed. By comparing social media data with biomedical literature, we identified 25 novel symptoms that were specifically mentioned in tweets but have been not previously well characterized. Furthermore, there were certain combinations of symptoms that were frequently mentioned together in social media. Conclusions: Identified outcome-specific risk factors, symptoms, and combinations of symptoms may serve as surrogate indicators to identify patients with COVID-19 and predict their clinical outcomes in order to provide appropriate treatments.